LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
Agreement signedPublished 31 Mar 2026

SCYNEXIS, Inc. /
Poxel

SCYNEXIS completes acquisition of AMPK program from Poxel

Buy side: SCYNEXIS, Inc.
Buy sideSCYNEXIS, Inc.
Target: Poxel
TargetPoxel
SCYNEXIS Inc · 31 Mar 2026Source
See the source
Buy side: SCYNEXIS, Inc.
Buy sideSCYNEXIS, Inc.
Target: Poxel
TargetPoxel
01 / BuyerSCYNEXIS, Inc.
02 / TargetPoxel
Source for the buyer and target: SCYNEXIS Inc

For the buyer and target.

“SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company focused on developing innovative new therapies to address severe rare diseases, today announced that it has entered into a definitive agreement with Poxel S.A. (POXEL.PA) to acquire PXL-770 (now SCY-770).”

Published 31 Mar 2026

Open the source
01

What happened

SCYNEXIS has agreed to acquire a set of direct AMP kinase activator research and development assets from Poxel SA, including the compound PXL-770, which is now called SCY-770. The upfront payment is $8 million, with additional milestone payments tied to development and commercial events. [01]

The company is positioning SCY-770 as a treatment candidate for autosomal dominant polycystic kidney disease, a rare kidney disorder. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · SCYNEXIS Inc

SCYNEXIS completes acquisition of AMPK program from Poxel

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by SCYNEXIS Inc

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.